Facilities
State-of-the-art facilities powering your program's success.
We provide our clients flexibility by offering endless options and work with you to align timelines.
Mammalian Protein Sites
We are known for our state-of-the-art CDMO campuses and purpose-built facilities designed to support mammalian protein needs. Our facilities feature advanced single-use bioreactors and flexible CGMP suites tailored for efficient and scalable production of biologics. We provide end-to-end solutions with an unwavering commitment to quality and personalized care.
Early Phase Center of Excellence
Costa Mesa, California
Avid’s Early Phase Center of Excellence in Costa Mesa is purpose-built for speed, flexibility, and technical precision. Designed around a single-use, agile manufacturing model, the facility supports rapid progression from DNA to IND, enabling sponsors to move from sequence to clinical supply with clarity and control.
The site integrates process development, analytical development, and early-phase CGMP manufacturing in a highly collaborative environment, reducing tech transfer risk and compressing timelines. With right-sized bioreactor capacity and modular cleanroom design, Costa Mesa is optimized for Phase I and early Phase II programs that require responsiveness, adaptability, and deep technical engagement.
This facility is ideal for emerging biotechs and fast-moving pharma programs seeking an experienced partner that can accelerate development without overbuilding infrastructure too early.
Clinical & Commercial Manufacturing
Tustin, California
Avid’s Tustin campus is a fully integrated mammalian protein process development and CGMP manufacturing facility supporting late-stage clinical and commercial biologics production.
Spanning approximately 160,000 sq. ft., the site has produced more than 600 CGMP batches and features over 20,000L of installed single-use bioreactor capacity.
Designed for scalability, reliability, and regulatory excellence, Tustin supports technology transfer, process characterization, PPQ campaigns, and sustained commercial supply.
With extensive experience supporting global regulatory submissions and commercial launches, the Tustin facility provides the operational depth and manufacturing strength required for Phase III and market-ready biologics.